title: Appropriate response to influenza A (H1N1) virus vaccination in patients with inflammatory bowel disease on maintenance immunomodulator and/or biological therapy.
authors.forename: Tamás
authors.initials: T
authors.lastname: Molnár
authors.forename: Klaudia
authors.initials: K
authors.lastname: Farkas
authors.forename: István
authors.initials: I
authors.lastname: Jankovics
authors.forename: Márta
authors.initials: M
authors.lastname: Melles
authors.forename: Ferenc
authors.initials: F
authors.lastname: Nagy
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szepes
authors.forename: Tibor
authors.initials: T
authors.lastname: Wittmann
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology*; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control* / Q000821:virology; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007155:Immunologic Factors; D007252:Influenza Vaccines; D014409:Tumor Necrosis Factor-alpha